Latest news

Clear filters

Mathys & Squire recommended in latest edition of WTR 1000

Mathys & Squire is delighted to announce that our trade mark team has been recommended in the latest World Trademark Review (WTR) 1000 guide Praised for “having a specialised knowledge of… read more…

Could innovation in artificial photosynthesis help mitigate global climate catastrophe?

On 24 January 2023, the Science and Security Board (SASB) of the Bulletin of the Atomic Scientists announced that the hands of the Doomsday Clock have been moved forward The clock, which is a… read more…

How much is your IP worth? IP valuation – is it a myth, mystery or something more valuable?

Peter Drucker and Edwards Deming are most often cited as saying that “you can’t manage/improve what you don’t measure” How do you know which intellectual property (IP) rights to devote more… read more…

Ownership of academic inventions: ‘The Oxford Decision’

A recent judgement has been handed down relating to ownership of employee inventions in an academic context which is of relevance to all universities in the UK The decision of Oxford University… read more…

T 464/20: Public prior use and standard of proof

According to the existing case law of the Boards of Appeal, the standard of proof applicable to allegations of public prior use – when the evidence is in the sphere of both parties – is ‘the… read more…

2022 recap: IP, science and technology trends that shaped last year

From developments in the world of artificial intelligence (AI) and machine learning (ML), to the exploration of space, there have been numerous advancements and trends in the fields of science and… read more…

JUVE Patent recommends Mathys & Squire patent team and five Partners in its 2023 UK rankings

Mathys & Squire is delighted to have been recognised in JUVE Patent’s UK rankings 2023  We are pleased to report that we have had a record number of Partners individually recommended in… read more…

Four Mathys & Squire Partners recognised in IAM Strategy 300 Global Leaders 2023

Mathys & Squire Partners Anna Gregson, Dani Kramer, Sean Leach and Martin MacLean have been featured in the 2023 edition of IAM Strategy 300 Global Leaders The guide showcases the top experts… read more…

Gummies – Something for pharma to chew on?

Data and commentary provided by Mathys & Squire has featured in an article by Nutraceuticals World, providing an update on the growth of the medicinal gummies market A condensed version of… read more…

1 6 7 8 9 10 11 12 13 14 15 16 74